Introduction {#sec1-1}
============

Opioids have long been a cornerstone of pain management in both human and veterinary anaesthesia. They provide analgesia, sedation and anaesthetic sparing effects, and often contribute significantly to haemodynamic stability during surgery and anaesthesia. Opioid use is not without side effects that can include well recognised clinically significant respiratory depression, ileus and potential for development of addiction and tolerance in both humans (Ronald and Kissin, 1998) and animals (Martin and Eades, 1961; Kissin *et al.*, 1991). Currently there is a growing body of evidence, from both human and animal studies, supporting a condition of opioid-induced hyperalgesia OIH (Lee *et al.*, 2011; Pasero and McCaffery, 2012). There has been a recognition of the negative immunomodulatory effects of some opioids (Sacerdote, 2006; Odunayo *et al.*, 2010; Levite, 2012) and even an association of increased rates of cancer recurrence with opioid use (Cata *et al.*, 2016).

Opioid-induced hyperalgesia can occur in a subset of patients, for currently undefinable reasoning. Increased post-operative pain scores and opioid requirements have been reported in people following administration of a single opioid-containing anaesthetic (Sukhani *et al.*, 1996; Chia *et al.*, 1999; Guignard *et al.*, 2000; Bakan *et al.*, 2015). Administration of opioids initially produces analgesia but after a period of time hyperalgesia may be induced (Angst and Clark, 2006). While the condition itself is still poorly understood, the seriousness of a hyperalgesic state for postoperative patients has provided the motivation for the fast growing practice of opioid-free anaesthesia (OFA) in human medicine. Additional reported benefits of OFA include reduced post-operative opioid requirements (Feld *et al.*, 2003; Mansour *et al.*, 2013; Bakan *et al.*, 2015), reduced incidence of post-operative nausea and vomiting (Mather and Peutrell, 1995; Callesen *et al.*, 1999; Ziemann-Gimmel *et al.*, 2014; Bakan *et al.*, 2015), reduced intraoperative hypotension (Jagannathan *et al.*, 2007; Bakan *et al.*, 2015), and reduced post-operative sedation levels (Feld *et al.*, 2003). Opioids provide the mainstay of analgesia in a significant proportion of veterinary anaesthesia. Veterinarians are familiar with their use and perioperative effects. The use of OFA provides a difficult challenge with loss of this familiarity. However it is likely there is a subset of veterinary patients that are also susceptible to OIH and arguable that our oncologic and immunodeficient patients may also benefit from OFA (Celerier *et al.*, 2000; Cabanero *et al.*, 2009). OFA highlights the need for a multimodal drug approach to ensure the patient receives an opioid-free, but not analgesic-free, anaesthetic and post-anaesthetic experience. This report presents three cases that underwent successful OFA, with a protocol the authors consider an acceptable baseline for more invasive surgeries, and with a potential for prospective randomized studies.

Case details {#sec1-2}
============

All cases discussed were presented to the University Veterinary Teaching Hospital Sydney (UVTHS), for routine ovariohysterectomy, through the teaching neuter program.

Case 1 {#sec2-1}
------

A 6-month-old Bull Terrier was presented for ovariohysterectomy. The owner reported no current health concerns but noted a previous episode of conjunctivitis one month prior to presentation. The dog's physical examination findings were unremarkable. Her demeanour was noted to be quiet and friendly.

Case 2 {#sec2-2}
------

A 2-year-old Shetland Sheepdog presented for ovariohysterectomy. The dog was current on her vaccination schedule with no ill-health reported by the owner. Physical exam of the dog revealed a grade II/VI heart murmur, with point of maximum intensity over the left heart base. The owner declined cardiac work up, however, reported no clinical signs of cardiac disease. The dog's demeanour was noted to be bright, alert and responsive.

Case 3 {#sec2-3}
------

A 5-year-old Labrador was presented for ovariohysterectomy. The owner reported no health concerns. The dog had whelped three months prior to presentation. Physical examination was unremarkable. The dog was noted to be very timid and nervous of people.

Procedures {#sec2-4}
----------

Dogs underwent the standard pre-anaesthetic protocol of the teaching hospital neuter clinic, performed by final year veterinary students during their anaesthesia clinical training rotation. This included physical examination, basic pre-anaesthetic blood testing (PCV/TP), preoperative behaviour scoring (Romano *et al.*, 2015) and assignment of ASA health status score ([Table 1](#T1){ref-type="table"}).

###### 

Pre-anaesthetic blood testing (PCV/TP), ASA health status score, perioperative sedation scoring, intraoperative anaesthetic complications, post-operative recovery scoring, and post- operative pain scoring for each case.

  Parameter                         Case 1   Case 2              Case 3
  --------------------------------- -------- ------------------- -------------------
  PCV/TP                            51/66    43/60               58/62
  ASA                               1        2                   1
  Sedation Score (/15)              10       6                   6
  Anaesthetic complications         H.       SR (surgical). H.   SR (surgical). H.
  Recovery Score (/4)               1        1                   1
  PS 1 (/25) (alert and response)   1        3                   1
  PS 2 (+60mins)                    1        8                   2 (4pm)
  PS 3 (+120 mins)                  3        4                   2
  PS 4 (+180mins)                   2        0 (4pm)             2
  PS 4pm                            1        0                   2
  PS 8pm                            2        0                   6
  PS12 midnight                     1        1                   2
  PS 4am                            2        0                   2
  PS 8am                            0        0                   2

(SR): intraoperative sympathetic response; (H): hypothermia (\<37°C); (PS): Pain score.

Perioperative patient assessments included sedation scoring (Gurney *et al.*, 2009), recovery scoring (Becker *et al.*, 2013) and post-operative pain scoring (Reid *et al.*, 2007), performed by students with guidance from an anaesthetist ([Table 1](#T1){ref-type="table"}).

The UVTHS neuter clinic protocol dictates that sedation scoring is performed immediately prior to induction. Recovery scoring is performed immediately after extubation. Post-operative pain scoring is initially performed when the dog is extubated and responsive, and thereafter hourly for three hours (by anaesthesia students). Once transferred to recovery ward dogs' pain was scored every four hours (by recovery ward nursing staff) until discharge time (the following morning).

The same anaesthetist managed all three cases. OFA was achieved with a pre-anaesthetic medication of varying doses of medetomidine (Domitor, Pfizer Animal Health, Australia), ketamine (Ceva Ketamine, Ceva Animal Health Pty Ltd, Australia) and acepromazine (A.C.P.2, Delvet, Australia). All drugs were mixed in a single syringe and administered intramuscularly.

Anaesthesia was induced intravenously with alfaxalone (Alfaxan, Jurox, Australia) or alfaxalone and lidocaine (Lignocaine Injection 2%, Pfizer Animal Health, Australia) co-induction. Anaesthesia was maintained with Isoflurane (Isothesia, Henry Schein, Australia) in oxygen.

Medetomidine and ketamine infusions were administered intraoperatively for analgesia and minimum alveolar concentration (MAC) sparing effects to improve the dogs' haemodynamics. Sympathetic response (dramatic or sustained increases in heart rate and blood pressure) was viewed as light plane of anaesthesia for the level of surgical stimulation and was treated with either adjustment in isoflurane concentration or intraoperative injection of analgesia (ketamine or lidocaine). Transversus abdominis plane (TAP) regional anaesthesia with bupivacaine (Bupivacaine Injection BP 0.5%, Pfizer Animal Health, Australia) 4mg/kg was performed in all cases. Carprofen (Carprieve, Norbrook Laboratories, Australia Ltd, Australia) 4mg/kg was administered subcutaneously and paracetamol (Paracetamol Kabi, Fresenius Kabi Australia Pty Ltd, Australia) 10mg/kg intravenously during the preoperative or intraoperative period.

Atracurium (Atracurium Besylate Injection, Hospira Australia Pty Ltd, Australia) was administered to one of the three cases (Case 2) as required to assist mechanical ventilation. All three cases were monitored with use of pulse oximetry, capnography, non-invasive (appropriately sized cuff placed on antebrachium) or invasive blood pressure (arterial catheter placed in dorsal pedal artery), volatile anaesthetic monitoring, intraoperative oesophageal and post-operative rectal temperatures. Animals were visually monitored continuously in recovery until alert and responsive, standing and having a rectal temperature above 37 degrees Celsius. Active warming was provided with a warm air blanket (Warm Air Blanket, Darvall Vet, Australia).

The protocol was varied with each case as indicated by individual patient factors and for improvement of the overall technique ([Table 2](#T2){ref-type="table"}).

###### 

OFA protocol for each case.

  Drugs                                                 Case 1    Case 2     Case 3
  ----------------------------------------------------- --------- ---------- ----------
  Medetomidine (ug/kg) IM                               10        5          10
  Ketamine (mg/kg) IM                                   2         2          2
  Acepromazine (mg/kg) IM                               0.02      0.02       0.02
  Alfaxalone (mg/kg) IV                                 0.4       2          2.7mg/kg
  Lidocaine (mg/kg) IV                                  1         \-         \-
  Isoflurane (ET%)                                      0.8-1.4   0.9-1.1    0.9-1.3
  Ketamine CRI (ug/kg/min) /total dose (mg/kg)          10/0.8    5-10/1.2   10/1.3
  Lidocaine CRI (ug/kg/min) /total dose (mg/kg)         50/1.3    \-         \-
  Dex/Medetomidine CRI (ug/kg/hr) /total dose (ug/kg)   M2/2.4    M2/4.6     M2/4.4
  Ketamine bolus IV /(total dose mg/kg)                 N         N          Y (0.5)
  Lidocaine bolus IV /(total dose mg/kg)                N         N          Y (2)
  TAP block                                             Y         Y          Y

Case 1 received the highest sedation score of 10/15. It should be noted Case 1 was assessed to be quiet and friendly preoperatively compared with the following two cases that were noted to be bright, alert and responsive or nervous and timid preoperatively, and as such this difference in patient factors may have contributed to the heavier sedation level achieved. Case 1 utilised lidocaine as a co-induction agent and this likely contributed to a dose sparing effect of alfaxalone. For Case 2, the premedication dose of medetomidine was half that of Case 1 with no change to the dosing of ketamine or acepromazine. Although heavy sedation was achieved (sedation score 9/15) the dog was also noted to be dysphoric. Subsequent to this a high dose of alfaxalone was required to induce anaesthesia. Lower end-tidal isoflurane concentrations were used to maintain anaesthesia with no intraoperative analgesia boluses required.

However, Case 2 had the only pain score \>5/24 in the first three hours post-operatively. Case 2 was administered methadone analgesia however the dog's pain score did not improve with this. The increased score was deemed to be primarily anxiety based and was successfully treated with acepromazine (0.01mg/kg) intravenously. In an attempt to eliminate the possibility of dysphoria Case 3 received a higher dose of medetomidine, as also previously given to Case 1. Although the dog did not appear dysphoric she did show muscle rigidity, suspected secondary to ketamine administration. Subsequently a higher dose of alfaxalone was required to induce anaesthesia. Postoperative pain scoring for Case 3 remained low with no post-operative opioids required.

Anaesthetic complications included increases in heart rate and blood pressure, and hypothermia (\<37°). No episodes of intraoperative hypotension occurred. Hypothermia resolved within two hours postoperatively in all dogs. The recovery scores of all dogs reflected excellent post-operative recoveries.

Discussion {#sec1-3}
==========

OFA is possible for dogs undergoing routine ovariohysterectomy. OFA was achieved in a series of three cases using a multimodal drug approach including medetomidine, ketamine, carprofen, paracetamol and bilateral TAP regional anaesthesia with bupivacaine. The long-standing use of opioids in veterinary anaesthesia has led to a familiarity of their effects during anaesthesia. Opioids are potent analgesics with significant MAC sparing effects. The UVTHS neuter clinic utilises the MAC-sparing effects of opioids in the vast majority of anaesthetics. Loss of this familiarity with increasing use of OFA has brought with it several challenges. The use of a multidrug approach was deemed essential for OFA to ensure adequate analgesia. The protocol presented was developed based on currently used opioid-free protocols in human anaesthesia (Bakan *et al.*, 2015; Mulier, 2016). With each case came increased familiarity of the drug combinations resulting in increased competence in performing OFA.

Medetomidine is a selective alpha-2 agonist drug providing analgesia, sedation and sympatholysis with significant opioid sparing effects (Blaudszun *et al.*, 2012). Alpha-2 agonist analgesic doses can be variable and the duration of analgesia is unreliable (Sinclair, 2003). Medetomidine can be used in combination with an opioid, rather than a potential substitute, to improve its analgesic effects (Kuo and Keegan, 2003), providing a potential drawback of OFA. Alpha-2 agonist drugs are considered core components in many human OFA protocols (Bakan *et al.*, 2015; Mulier, 2016). Ketamine is a dissociative agent with NMDA receptor antagonism and sympathomimetic effects (Peltoniemi *et al.*, 2016). At low doses it provides analgesia, while also providing anaesthesia at high doses (Peltoniemi *et al.*, 2016). It is thought to provide less intense analgesia than pure-µ opioids and is often used in combination with an opioid for multimodal analgesic effects (Carstensen and Moller, 2010; Gutierrez-Blanco *et al.*, 2015).

Ketamine is a common component of OFA in people and has even been shown to reduce the development of OIH if administered prior to opioid treatment in animals (Celerier *et al.*, 2000) and humans (Hong *et al.*, 2011; Kaur *et al.*, 2015). The dysphoria reported for Case 2 after premedication was believed to be secondary to ketamine administration. Continuation of ketamine intraoperatively may also have contributed to the post-operative anxiety shown by the dog. Subanaesthestic doses of ketamine have been shown to cause adverse behaviour changes in humans (Krystal *et al.*, 1994).

Case 3 experienced muscle rigidity following premedication and this was again considered a side effect of ketamine administration. These side effects are potential drawbacks of utilizing ketamine within opioid free protocols. Ketamine is often omitted or used at lower doses when combined with opioids.

Intravenous lidocaine has been shown to have analgesic and anti-inflammatory effects (Rang *et al.*, 2012). Intraoperative intravenous lidocaine infusion can reduce inhalational anaesthetic requirements, reduce post-operative pain scores and opioid requirements (McCarthy *et al.*, 2010).

Carprofen and paracetamol have been used as adjunct analgesics in these cases. Although they do not contribute an anaesthetic sparing effect they add to the multimodal approach that is essential when considering OFA. Carprofen is a non-steroidal anti-inflammatory analgesic with COX-2 inhibitory effects. Carprofen has been shown to be safe and efficacious when given preoperatively to healthy animals undergoing fracture repair (Bergmann *et al.*, 2005).

Paracetamol is a centrally acting analgesic with mild to moderate effects (Rang *et al.*, 2012). Paracetamol is not commonly used in veterinary medicine compared to its use in human medicine, however it is widely used at the UVTHS. Species variation in use, and specifically acute toxicity effects in felines, and a lack of familiarity are likely significant contributors to the reduced use of paracetamol in veterinary medicine. Although not often used on its own paracetamol has been shown repeatedly to provide significant opioid-sparing effects in humans (Korpela *et al.*, 1999; Remy *et al.*, 2005; Sinatra *et al.*, 2005; Maund *et al.*, 2011). Mburu *et al*. (1988) reported a 33% reduction in post-operative surgical site swelling and 47% reduction in pain in dogs treated with paracetamol compared with placebo after undergoing experimental forelimb surgery. Paracetamol was well tolerated in the cases presented with no adverse effects seen.

When preparing an OFA technique, a great amount of effort must go into ensuring an effective multimodal approach is achieved, as one of the potential drawbacks associated with the practice of OFA is inadequate analgesia. Traditional opioid anaesthetic (OA) techniques for routine ovariohysterectomies at UVTHS involve the use of opioids and non-steroidal anti-inflammatories. Premedication is usually achieved with medetomidine and/or acepromazine, as done in this OFA technique. The addition of intraoperative constant rate infusions of medetomidine and ketamine, and lidocaine boluses were the mainstay of the OFA techniques presented. Regional anaesthesia in the form of TAP block with bupivacaine was viewed as only adjunctive analgesia and believed to likely be of greatest benefit post-operatively for the laparotomy wound.

There were notable differences of OFA to OA. The first occurred with premedication. A standard premedication for OA at the UVTHS involves use of a sedative and opioid. For these OFA cases the opioid was essentially substituted with ketamine and medetomidine. The dose of medetomidine required to achieve the same level of sedation that would be expected when combined with morphine was approximately double than when combined with ketamine and midazolam.

This highlighted the clinically significant synergistic effects of adding an opioid to medetomidine, especially when considering the lower level of sedation that is expected when morphine is given on its own. Acepromazine was administered to Case 2 post-operatively after the dog showed signs of anxiety on recovery and following no response to methadone analgesia trial bolus. It is unlikely the sedative effects of the ketamine and medetomidine were remaining during recovery, with acepromazine the only long-acting drug utilized in this protocol. This varies significantly from traditional OA techniques where longer acting opioids, such as morphine and methadone, are often given as part of the premedication, providing ongoing sedative effects and contributing to recovery quality.

The second notable difference, and arguably the most clinically relevant, was a lack of hypotension during OFA. Hypotension is one of the most common complications of anaesthesia (Gaynor *et al*. 1999). Increase in blood pressure can be a sign of sympathetic response to surgical stimulation. Initial management of dramatic or sustained increases in blood pressure included increasing anaesthetic depth or provision of an analgesic dose of ketamine intravenously. However a lack of response to such measures and lack of physical indicators of light plane of anaesthesia (eye position, jaw tone) resulted in recognition of blood pressure values in the high normal range to be secondary to our combination of anaesthetic drugs. Increasing the depth of anaesthesia of the dogs at this time resulted in physical indicators of deep anaesthesia (centrally placed eyes and lack of jaw tone).

The most likely contributor was the peripheral vascular effects of medetomidine with subsequent vasoconstriction. These results are consistent with those of Bakan *et al*. (2015) who compared OFA with propofol, dexmedetomidine and lidocaine infusions with opioid anaesthesia of propofol and remifentanil infusions and found the OFA group had only 3% of patients requiring use of ephedrine for treatment of hypotension compared with 20% of the OA group. Furthermore 28% of the OFA group actually required treatment for hypertension while none of the OA group did. As the authors' experience with OFA increased the recognition of increased blood pressure values as drug effects lead to greater comfort level with management of the anaesthesia and subsequently comfort in appropriately using lower inhalational levels.

All dogs had a smooth initial recovery with low recovery scores at extubation. Analgesia was administered to Case 2 to ensure pain was not a component of the anxious behaviour shown post-operatively (with no response). The lack of pain in all dogs on recovery was somewhat unexpected with an almost expected pain response in the face of opioid omission.

Use of OFA will continue to be a growing field in human medicine and will likely be of benefit to a particular subset of veterinary patients. Development of OFA protocols for more invasive, advanced surgeries can occur once the anaesthetist is comfortable performing OFA in less invasive, commonly performed surgeries such as ovariohysterectomy.
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